Heritage Investment Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$772K Hold
3,068
0.1% 58
2026
Q1
$667K Hold
3,068
0.1% 63
2025
Q4
$701K Buy
3,068
+236
+8% +$53.8K 0.11% 60
2025
Q3
$656K Hold
2,832
0.11% 62
2025
Q2
$526K Hold
2,832
0.09% 68
2025
Q1
$593K Hold
2,832
0.11% 53
2024
Q4
$503K Hold
2,832
0.09% 61
2024
Q3
$559K Hold
2,832
0.11% 52
2024
Q2
$486K Hold
2,832
0.1% 52
2024
Q1
$516K Hold
2,832
0.11% 54
2023
Q4
$439K Hold
2,832
0.1% 54
2023
Q3
$422K Buy
2,832
+169
+6% +$24.8K 0.12% 54
2023
Q2
$359K Hold
2,663
0.1% 57
2023
Q1
$424K Buy
2,663
+84
+3% +$12.8K 0.13% 46
2022
Q4
$417K Hold
2,579
0.13% 46
2022
Q3
$346K Hold
2,579
0.21% 51
2022
Q2
$395K Hold
2,579
0.23% 50
2022
Q1
$418K Buy
+2,579
New +$375K 0.3% 48

Other funds holding ABBV

Heritage Investment Group's ABBV Position: Q2 2026 in Review

Heritage Investment Group held its AbbVie (ABBV) position steady in Q2 2026 at 3,068 shares worth $772K. The position accounts for 0.1% of the portfolio, ranked #58.

Heritage Investment Group first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Heritage Investment Group held 3,068 shares of AbbVie worth $772K as of Q2 2026.
  • Heritage Investment Group left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.1% of Heritage Investment Group's portfolio in Q2 2026, its #58 holding.
  • Heritage Investment Group first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • 4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Heritage Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.